Literature DB >> 21317863

Update on treatment options for newly diagnosed ovarian cancer.

Deborah Armstrong1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21317863

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  8 in total

1.  CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.

Authors:  Margaret Gil; Marcin P Komorowski; Mukund Seshadri; Hanna Rokita; A J Robert McGray; Mateusz Opyrchal; Kunle O Odunsi; Danuta Kozbor
Journal:  J Immunol       Date:  2014-10-15       Impact factor: 5.422

2.  Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism.

Authors:  Jianqun Liao; Feng Qian; Nana Tchabo; Paulette Mhawech-Fauceglia; Amy Beck; Zikun Qian; Xinhui Wang; Wendy J Huss; Shashikant B Lele; Carl D Morrison; Kunle Odunsi
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

3.  E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.

Authors:  Xiu-Bo Sang; Zhi-Hong Zong; Li-Li Wang; Dan-Dan Wu; Shuo Chen; Bo-Liang Liu; Yang Zhao
Journal:  Oncotarget       Date:  2017-02-28

4.  FOXA1 can be modulated by HDAC3 in the progression of epithelial ovarian carcinoma.

Authors:  Tong Lou; Chongdong Liu; Hong Qu; Zhiqiang Zhang; Shuzhen Wang; Huiyu Zhuang
Journal:  J Transl Med       Date:  2022-01-06       Impact factor: 5.531

5.  Establishment, characterization and downstream application of primary ovarian cancer cells derived from solid tumors.

Authors:  Thanasak Sueblinvong; Rahel Ghebre; Yoshie Iizuka; Stefan E Pambuccian; Rachel Isaksson Vogel; Amy P N Skubitz; Martina Bazzaro
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

6.  Epithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigens.

Authors:  Xiaofen Yao; Zhangli Dong; Qiuwan Zhang; Qian Wang; Dongmei Lai
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

7.  Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition.

Authors:  Nadia Lobello; Flavia Biamonte; Maria Elena Pisanu; Maria Concetta Faniello; Žiga Jakopin; Emanuela Chiarella; Emilia Dora Giovannone; Rita Mancini; Gennaro Ciliberto; Giovanni Cuda; Francesco Costanzo
Journal:  Oncotarget       Date:  2016-09-20

8.  LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway.

Authors:  Ran Cui; Guangming Cao; Huimin Bai; Zhenyu Zhang
Journal:  Cancer Cell Int       Date:  2019-07-29       Impact factor: 5.722
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.